Skip to content
Screener

Revvity RVTY Life Sciences — Restructuring and Other Costs (Income)

Other segment segments

Diagnostics
$7.55M+5,496%

Similar metrics at other companies

Clarivate logo
CLVTLife Sciences & Healthcare — Restructuring costs
$1.2M-62.5%
MSC Industrial Direct Co. logo
MSMReportable Segment — Restructuring and other costs
$0-100%
Matrix Service Company logo
MTRXCorporate Segment — Restructuring costs and other
$1.99M—
Twist Bioscience Corporation logo
TWSTReportable Segment — Restructuring and other costs
$0—
Herbalife logo
HLFOthers — Restructuring Costs
$0—
Hooker Furnishings Corporation logo
HOFTAll Other — Restructuring Costs
$5K-87.5%

Other financials

Income statement

See full
Revenue$711.1M+7.0%
Gross profit$387.7M+3.2%
Operating income$75.9M+5.1%
Net income$40.7M-3.6%
EPS (diluted)$0.36+2.9%

Balance sheet

See full
Cash & equivalents$861.5M-24.3%
Total debt$3.9B+17.8%
Total equity$7.2B-5.9%
Total assets$12.0B-2.9%

Cash flow

See full
Operating cash flow$115.2M-10.1%
CapEx$19.8M+23.7%
Free cash flow$95.5M-14.9%

Valuation

See full
Market cap$12.83B+28.7%
Enterprise value$15.91B+28.6%
P/E53.5×+18.6×
P/S4.4×+0.9×

Profitability

See full
Gross margin48.5%—
Operating margin12.4%-1.1pp
Net margin8.3%-2.1pp
FCF margin17%-1.9pp

Returns & leverage

See full
Return on equity3.2%-0.5pp
Debt / equity0.5×+0.1×
Current ratio1.7×-1.9×

Where this comes from

Reported directly by Revvity in its filing.

Tagged under the XBRL concept us-gaap:RestructuringCosts.

The source filing: Revvity’s 10-Q, filed May 12, 2026.

Filed
May 12, 2026, 4:07 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0000031791-26-000019
Line itemThree Months Ended / April 5,2026Three Months Ended / March 30,2025
Life Sciences$3,229$2,528
Diagnostics7,554135
Corporate(108)576
$10,675$3,239

Item 1.Unaudited Financial Statements

FAQ

What is Revvity's life sciences — restructuring and other costs (income)?
Revvity (RVTY) reported life sciences — restructuring and other costs (income) of $3.23M in Q1 2026.
How has Revvity's life sciences — restructuring and other costs (income) changed year-over-year?
Revvity's life sciences — restructuring and other costs (income) increased by 27.7% year-over-year, from $2.53M to $3.23M.
What does life sciences — restructuring and other costs (income) mean?
Costs incurred for organizational realignments, facility consolidations, or workforce reductions within the Life Sciences segment. These are typically non-recurring expenses aimed at improving long-term operational efficiency.

Ask your AI about Revvity's life sciences — restructuring and other costs (income).

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude